KLSE (MYR): AHEALTH (7090)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
3.71
Today's Change
-0.05 (1.33%)
Day's Change
3.71 - 3.76
Trading Volume
19,000
Ann. Date | Date | Type | Units | Price | View |
---|
(吉隆坡3日讯)Apex保健(AHEALTH,7090,主板消费股)在新加坡的独资子公司 ——Apex Pharma Marketing(APM)获得国药(Sinopharm)疫苗供应合约。
Apex保健周五发文告指出,APM已在8月31日,和Innova生物医学公司签署供应协议,供应国药疫苗予新加坡私人诊所和医院。
该公司补充,第一批疫苗供应量为3万1600剂,会在9月中到货。
周五闭市,Apex保健收报3.01令吉,无起落,有1万8200股易手。
2021-09-04 11:36
people expected AHEALTH would get the benefit when the pandemic started. Unfortunately its revenue and profit have been so-so for 6 quarters. Disappointed. it will not surprise me if its share price is going back to the price before the pandemic.
2021-10-09 16:54
长期空头,而且季均线以下。手上有的只能做短线,近期跌破sma5出场
https://www.youtube.com/watch?v=voWmOcBQyb4
2022-01-03 04:03
Ahealth is my hope. Dont let down
Why poor people need to suffer in life.
Not much opportunity to young people
Must be suffering life if no background
2022-07-04 17:15
Healthcare stocks will do well in high inflation environment, except glove companies with large CAPex
2022-07-12 22:09
no reason, don't simply spread fake news causing other people panic.
you definitely is a bad guy.
2022-09-01 15:42
Dr Kee buy also…..so you decide la. For me, I’m not selling. This stock will reward long term shareholder
2022-09-08 12:18
normal people need to try their luck
but why rich people can earn money so easily..?
2022-11-16 15:00
Apex Healthcare Berhad (KLSE:AHEALTH) Third Quarter 2022 Results
Key Financial Results
Revenue: RM232.1m (up 10.0% from 3Q 2021).
Net income: RM26.9m (up 92% from 3Q 2021).
Profit margin: 12% (up from 6.6% in 3Q 2021). The increase in margin was driven by higher revenue.
EPS: RM0.057 (up from RM0.03 in 3Q 2021).
2022-11-18 08:55
This is one of the best stock in klse.
You will be regretted if you miss this opportunity to buy in now @RM 3.40. 5 years later you will feel fortunate that you have made this right decision.
I topped up @ RM 3.40
Trust me.
2022-11-18 09:00
this one following in the footsteps of Kotra. Solid business even in recession times..
2022-12-20 11:11
Quality pharma stocks like Kotra and Apex are underrated. Slowly and quietly go up is good..
2 months ago
You are just fighting against prop traders at this time. The perfect moment to buy Kotra Industries was 1 year ago December 2021
2 months ago
Breaking news: China ban medicine and glove export due to high demand to avoid shortage!
2 months ago
Public Bank hold rating. Which means this stock will pump up at least 20%. Still have meat on the table
3 weeks ago
@wall, mind sharing with us why Public Bank suggest hold but still have meat available..
3 weeks ago
The trend and behavior of AHealth for me resembles of Public Bank. Create value to shareholders in long term.
3 weeks ago
Nepo
3 Sept 2021
Apex Healthcare Bhd said it has inked an agreement with Innova Bio-Medical Pte Ltd to supply the Sinopharm Covid-19 vaccine to private healthcare practitioners in Singapore. Innova is part of the Innova Medical Group, a global company specializing in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke, and virus detection focused on infectious diseases. Under the deal, Innova will supply the Chinese-made vaccine to Apex’s wholly-owned unit in Singapore, Apex Pharma Marketing Pte Ltd, for onward sale and distribution to hospitals and private clinics within the city state, said Apex Healthcare.
2021-09-04 11:34